Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan/HCTZ vs Monotherapies in Japanese Hypertension
NCT00092209Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2002
- Primary completion
- Nov 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of losartan, hydrochlorothiazide in essential hypertension, sponsored by Organon & Co.. Started Apr 2002; status: completed.
02
Drugs
losartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00092209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092209.